Why do investors equate these companies with beautiful, mythical beasts? Because startups with such dazzling attributes are—or long were—rarely seen.

Scott Whitaker, the CEO of the industry lobby AdvaMed, told the Senate Finance Committee that he fears tariffs will only raise the cost of care and put patients at risk if companies are unable to overcome supply chain disruptions. 

Citing sources familiar with the matter, the Wall Street Journal reports that UnitedHealth Group is being investigated for criminal fraud, likely stemming from its Medicare Advantage billing practices. 

The unwanted spam calls were associated with Optum's home healthcare service. Plaintiffs alleged they received the marketing calls despite opting out and never signing up, in violation of federal consumer protection laws. The company does not admit to wrongdoing. 

A week after filing Chapter 11 bankruptcy, the liquidation of Rite Aid's remaining assets has begun. 

One Medical, a chain of primary care clinics owned by Amazon, is being sued by the family of a man who died due to alleged provider negligence. Now, court filings reveal staff improperly accessed the deceased man's protected medical records.

Andrew Witty is stepping down as CEO of UnitedHealth Group, citing "personal reasons."  Former CEO Stephen J. Hemsley has taken over, the company announced Tuesday.

A whistleblower lawsuit claims CVS pharmacies have overbilled state Medicaid programs for prescription drugs—a practice allegedly ongoing since 2016. The company denies any wrongdoing.